MoneyWorks4Me

SMS Pharma gets USFDA’s nod for manufacturing facility in Andhra

26 Dec 2015 Evaluate

SMS Pharmaceuticals has received approval from the US Food and Drug Administration (USFDA) for its manufacturing facility located at Kandivalasa village in Vizianagaram district of Andhra Pradesh. The USFDA had conducted inspection of the plant in the third week of April this year.

SMS Pharmaceuticals is engaged in manufacturing of active pharmaceutical ingredients (API) and currently has four production facilities and two research centers in operation.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..